GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma

$398,459
Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2022 · NS

Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer

$398,404
John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2023 · CA

Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer

$398,398
John Edward Moses · Cold Spring Harbor Laboratory · UG3 · FY2025 · CA

An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers

$398,375
Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA

Pathophysiologic Regulation of Fgf-23 in Phosphate Homeostasis: Role of Vitamin D

$398,325
Beate Lanske · Harvard Medical School · R01 · FY2007 · DK

Imaging tumor microenvironment by Optical Fiber-Tethered Simultaneous Lifetime-resolved Autofluorescence-Multiharmonic (OFT-SLAM) microscopy

$398,300
Haohua Tu · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA

Enhancing Viral Oncolysis with Vasculostatin Gene Delivery

$398,286
Balveen Kaur · Ohio State University · R01 · FY2011 · CA

Regulation of Tumor Oxygenation by BACH1 in Breast Cancer

$398,285
Marsha R Rosner · University Of Chicago · R01 · FY2023 · CA

Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma

$398,271
Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2018 · CA

POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE

$398,265
Suzie H Pun · University Of Washington · R01 · FY2015 · CA

Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity

$398,204
Guangyong Peng · Saint Louis University · R01 · FY2022 · CA

Volumetric time-lapse imaging of biophysical cell-extracellular matrix interactions for systems mechanobiology research

$398,142
Steven Graham Adie · Cornell University · R01 · FY2021 · GM

Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia

$398,092
Geoffrey L Uy · Washington University · P50 · FY2016 · CA

Endothelial plasticity in glioma vascularization and therapy resistance

$398,055
Yi Fan · University Of Pennsylvania · R01 · FY2021 · NS

Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers

$398,040
Mark Esposito · Kayothera Inc. · R43 · FY2023 · CA

Development of Novel CD180-Based Cancer Immunotherapeutics

$398,040
Edward A Clark · Abacus Bioscience Inc · R41 · FY2022 · CA

Mechanisms of linkage of stem and invasive phenotypes during metastatic colonization

$398,037
Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · P01 · FY2025 · CA

A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome

$398,030
Arvind P Pathak · Johns Hopkins University · R01 · FY2024 · CA

Roles of Glycoconjugates and Redox Signaling in Tumor Biology

$398,029
David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA

Skin Stem Cells and Their Niche Interactions

$398,027
Elaine Fuchs · Rockefeller University · R01 · FY2025 · AR

Improving treatment of brain metastases from HER2-positive breast cancer

$398,025
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2015 · CA

Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancer

$398,024
Zhihui Wang · Methodist Hospital Research Institute · R01 · FY2025 · CA

Volumetric time-lapse imaging of biophysical cell-extracellular matrix interactions for systems mechanobiology research

$398,011
Steven Graham Adie · Cornell University · R01 · FY2022 · GM

Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice

$398,001
Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

An interactive analysis toolkit for single cell RNA-seq in cancer research

$397,988
William Evan Johnson · Boston University Medical Campus · U01 · FY2017 · CA